RWG
TECH icon

Regal Wealth Group’s Bio-Techne TECH Stock Holding History

Regal Wealth Group’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-104
Closed -$3K – 185
2016
Q3 		$3K Hold
104
– – ﹤0.01% 173
2016
Q2 		$3K Hold
104
– – ﹤0.01% 179
2016
Q1 		$2K Hold
104
– – ﹤0.01% 174
2015
Q4 		$2K Buy
+104
New +$2.37K ﹤0.01% 170

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Regal Wealth Group's TECH Position: Q4 2016 in Review

Regal Wealth Group sold out of Bio-Techne (TECH) in Q4 2016, closing a stake of 104 shares — an estimated $3K sold.

Regal Wealth Group first reported a position in TECH in Q4 2015 and held it in 4 quarters. The position peaked at $3K in Q3 2016. 281 funds tracked by Wall St. Rank hold TECH as of Q4 2016.

  • Regal Wealth Group reported no remaining Bio-Techne position as of Q4 2016 after selling out during the quarter.
  • Regal Wealth Group sold 104 Bio-Techne shares in Q4 2016, an estimated $3K.
  • Regal Wealth Group first reported a position in Bio-Techne in Q4 2015 and held it in 4 quarters.
  • Regal Wealth Group's Bio-Techne position peaked at $3K in Q3 2016.
  • 281 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2016.

Based on Regal Wealth Group's 13F filing for Q4 2016, filed 9 Aug 2017.